Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.8987
+0.0905 (11.20%)
At close: Sep 2, 2025, 4:00 PM
0.8800
-0.0187 (-2.08%)
After-hours: Sep 2, 2025, 7:57 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $6.69 million as of September 2, 2025. Its market cap has increased by 39.59% in one year.
Market Cap
6.69M
Enterprise Value
-527.51K
1-Year Change
39.59%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $6.69M, a decrease of -89.75%. That is a compound annual growth rate of -43.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 6.69M | 67.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 230.89B |